QRG CAPITAL MANAGEMENT, INC.

Position in ZTS — Zoetis Inc.

CIK 1996454 BERWYN, PA

Position in ZTS

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$3,921,759

-$4,915,620 QoQ

Shares Held

54,575

-27.0% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#26

of 175 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $23,691,979 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (16.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	372,752	$5,975,214
2	ZTS	Zoetis Inc. This page	54,575	$3,921,759
3	HLN	Haleon plc	383,552	$3,578,540
4	NBIX	Neurocrine Biosciences Inc	18,903	$3,185,911
5	TEVA	Teva Pharmaceutical Industries Ltd	89,078	$3,017,962
6	UTHR	UNITED THERAPEUTICS Corp	3,476	$1,883,401
7	VTRS	Viatris Inc	49,564	$787,076
8	RDY	Dr Reddys Laboratories Ltd	41,233	$597,466

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,921,759	54,575	-27.0%	Shares	Sole	2026-07-14
2026-03-31	$8,837,379	74,760	+14.8%	Shares	Sole	2026-04-27
2025-12-31	$8,194,404	65,128	-6.8%	Shares	Sole	2026-02-02
2025-09-30	$10,224,110	69,875	-10.1%	Shares	Sole	2025-10-28
2025-06-30	$12,123,708	77,741	+4.9%	Shares	Sole	2025-07-21
2025-03-31	$12,204,681	74,125	-3.1%	Shares	Sole	2025-04-17
2024-12-31	$12,467,403	76,520	-0.4%	Shares	Sole	2025-02-05
2024-09-30	$15,015,148	76,851	+3.3%	Shares	Sole	2024-10-30
2024-06-30	$12,895,903	74,388	-1.9%	Shares	Sole	2024-07-12
2024-03-31	$12,832,378	75,837	+1.8%	Shares	Sole	2024-05-07
2023-12-31	$14,709,788	74,529	+3.4%	Shares	Sole	2024-02-07
2023-09-30	$12,534,911	72,048	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.